| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |